7-(4'-(2-nitroimidazole-1-yl)butyl)theophylline has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dennis, MF; Hill, SA; Hodgkiss, RJ; Stratford, MR | 1 |
| Hodgkiss, RJ; Webster, L; Wilson, GD | 1 |
2 other study(ies) available for 7-(4'-(2-nitroimidazole-1-yl)butyl)theophylline and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics and binding of the bioreductive probe for hypoxia, NITP: effect of route of administration.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Cell Hypoxia; Chromatography, High Pressure Liquid; Cyclodextrins; Dimethyl Sulfoxide; Drug Administration Routes; Flow Cytometry; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Nitroimidazoles; Peanut Oil; Plant Oils; Radiation-Sensitizing Agents; Theophylline | 1995 |
Measurement of hypoxia in vivo using a 2-nitroimidazole (NITP).
Topics: Adenocarcinoma; Animals; Cell Hypoxia; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Mammary Neoplasms, Experimental; Mice; Nitroimidazoles; Oxygen; Respiration; Sarcoma, Experimental; Theophylline | 1997 |